206 related articles for article (PubMed ID: 7589709)
1. The major histocompatibility complex in man.
Buc M
Folia Biol (Praha); 1995; 41(3-4):119-22. PubMed ID: 7589709
[No Abstract] [Full Text] [Related]
2. Conserved extended haplotypes of the major histocompatibility complex: further characterization.
Dorak MT; Shao W; Machulla HK; Lobashevsky ES; Tang J; Park MH; Kaslow RA
Genes Immun; 2006 Sep; 7(6):450-67. PubMed ID: 16791278
[TBL] [Abstract][Full Text] [Related]
3. The contribution of HLA genes to IBD susceptibility and phenotype.
Yap LM; Ahmad T; Jewell DP
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):577-96. PubMed ID: 15157829
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetics of the human major histocompatibility complex.
Duquesnoy RJ
Clin Lab Med; 1991 Sep; 11(3):509-36. PubMed ID: 1934962
[TBL] [Abstract][Full Text] [Related]
5. Genetic control of the immune system.
Hirschhorn K
Prog Clin Biol Res; 1981; 70():17-20. PubMed ID: 6796971
[No Abstract] [Full Text] [Related]
6. The genetics of HLA.
Schwartz DW; Felser B; Mayr WR
Folia Biol (Praha); 1995; 41(3-4):123-39. PubMed ID: 7589710
[No Abstract] [Full Text] [Related]
7. Molecular genetics of human major histocompatibility complex: clinical applications.
Partanen J; Koskimies S
Ann Clin Res; 1986; 18(5-6):271-6. PubMed ID: 3566166
[TBL] [Abstract][Full Text] [Related]
8. [The HLA gene complex].
Mayr WR
Infusionsther Transfusionsmed; 1994 Jun; 21(3):185-91. PubMed ID: 7919906
[TBL] [Abstract][Full Text] [Related]
9. [Immuno-genetics of celiac disease].
Mougenot JF; Sterkers G
Arch Fr Pediatr; 1988 May; 45(5):361-7. PubMed ID: 3137909
[No Abstract] [Full Text] [Related]
10. Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation.
Porter RR
Mol Biol Med; 1983 Jul; 1(1):161-8. PubMed ID: 6679872
[TBL] [Abstract][Full Text] [Related]
11. MHC class III polymorphisms in selection of donors for BMT.
Dorak MT; Chalmers EA; Sproul AM; Mills KI; Wilson DW; Galbraith I; Henderson N; Gibson BE; Burnett AK
Bone Marrow Transplant; 1993 Jan; 11(1):37-41. PubMed ID: 8094307
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor 2 allele does not contribute to increased tumor necrosis factor-alpha production in Sardinian multiple sclerosis.
Sotgiu S; Pugliatti M; Serra C; Rosati G; Dolei A; Marrosu MG
Ann Neurol; 1999 Nov; 46(5):799-800. PubMed ID: 10554002
[No Abstract] [Full Text] [Related]
13. What the clinician should know about the major histocompatibility complex.
Goldman JN; Goldman MB
JAMA; 1981 Aug; 246(8):873-6. PubMed ID: 6788966
[No Abstract] [Full Text] [Related]
14. Genetics of the HLA system.
Blann AD; Crichton WB
Med Lab Sci; 1988 Oct; 45(4):370-80. PubMed ID: 3151908
[No Abstract] [Full Text] [Related]
15. Localization of the genes for tumor necrosis factor and lymphotoxin between the HLA class I and III regions by field inversion gel electrophoresis.
Ragoussis J; Bloemer K; Weiss EH; Ziegler A
Immunogenetics; 1988; 27(1):66-9. PubMed ID: 3257100
[No Abstract] [Full Text] [Related]
16. [Tumor necrosis factor and lymphotoxin: molecular genetics, regulation and physiological role].
Nedospasov SA
Genetika; 2003 Feb; 39(2):207-14. PubMed ID: 12669416
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal.
Candore G; Balistreri CR; Colonna-Romano G; Lio D; Caruso C
Exp Gerontol; 2004 Apr; 39(4):645-52. PubMed ID: 15050301
[TBL] [Abstract][Full Text] [Related]
18. [Functional analysis of non-HLA genes within MHC region with knockout-mouse technology].
Matsumoto M
Seikagaku; 1999 May; 71(5):323-32. PubMed ID: 10391982
[No Abstract] [Full Text] [Related]
19. Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumour necrosis factor beta) gene.
Partanen J; Koskimies S
Scand J Immunol; 1988 Sep; 28(3):313-6. PubMed ID: 2904171
[TBL] [Abstract][Full Text] [Related]
20. The HLA system in human pathology.
Suciu-Foca N
Pathobiol Annu; 1979; 9():81-111. PubMed ID: 113764
[No Abstract] [Full Text] [Related]
[Next] [New Search]